Tower Research Capital LLC (Trc) Lava Therapeutics Nv Transaction History

Tower Research Capital LLC (Trc)

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.17 - $1.58 $585 - $790	-500 Reduced 4.18%	11,460 $18,000
Q2 2023 Aug 14, 2023	BUY	$1.4 - $2.6 $16,744 - $31,096	11,960 New	11,960 $24,000
Q3 2021 Nov 15, 2021	SELL	$5.5 - $11.0 $3,063 - $6,127	-557 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.8 - $16.0 $6,015 - $8,912	557 New	557 $6,000

3.61M

32.9K

500

Ticker LVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,797,700
Market Cap $26.8M
Description
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.